Strategy Asset Managers LLC Baxter International Inc Transaction History

Strategy Asset Managers LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$37.88 - $43.77 $181,520 - $209,745	4,792 New	4,792 $204,000
Q2 2023 Aug 24, 2023	SELL	$39.98 - $47.68 $23,268 - $27,749	-582 Reduced 10.83%	4,792 $218,000
Q3 2022 Oct 11, 2022	BUY	$53.86 - $66.8 $21,544 - $26,720	400 Added 8.04%	5,374 $289,000
Q4 2020 Feb 10, 2021	SELL	$75.39 - $82.36 $35,810 - $39,121	-475 Reduced 8.72%	4,974 $399,000
Q1 2020 May 14, 2020	BUY	$71.57 - $93.3 $33,995 - $44,317	475 Added 9.55%	5,449 $442,000
Q1 2019 May 08, 2019	SELL	$64.48 - $81.31 $1.28 Million - $1.62 Million	-19,908 Reduced 80.01%	4,974 $404,000
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $1.1 Million - $1.39 Million	-17,900 Reduced 41.84%	24,882 $1.64 Million
Q3 2018 Nov 01, 2018	SELL	$70.71 - $77.75 $88,387 - $97,187	-1,250 Reduced 2.84%	42,782 $0
Q2 2018 Aug 07, 2018	SELL	$63.43 - $75.41 $81,190 - $96,524	-1,280 Reduced 2.82%	44,032 $3.25 Million
Q1 2018 May 03, 2018	BUY	$62.56 - $72.26 $2.52 Million - $2.91 Million	40,338 Added 810.98%	45,312 $2.95 Million
Q2 2017 Aug 07, 2017	BUY	N/A	4,974	4,974 $301,000

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

Stay updated on Strategy Asset Managers LLC with notifications on news.